超越腔内解决方案:移植物保留下的开放瘤囊修复术治疗EVAR术后持续性主动脉瘤囊扩张
该研究回顾了奥克兰市医院2010年1月至2023年10月间因EVAR术后主动脉瘤囊扩张而行移植物保留的开放瘤囊修复术(OSR)的17例患者,中位随访3年。主要指征为瘤囊扩张伴2型内漏(88.24%),术中94.12%发现内漏。结论认为该技术有效,可识别并修复内漏同时避免主动脉阻断,但需持续监测。
要点
- EVAR术后瘤囊扩张行OSR并保留移植物,可识别并修复内漏且避免主动脉阻断。
- 17例患者中,主要指征为瘤囊扩张伴2型内漏(88.24%),2例为V型内漏。
- 17.65%患者(3/17)因瘤囊进展需再干预,30天死亡率为0%。
核心结论
- 移植物保留下的开放瘤囊修复术对EVAR术后瘤囊扩张有效,便于识别和修复内漏,同时避免主动脉阻断。
- 术后需要持续监测。
研究设计与样本
- 回顾性研究,纳入奥克兰市医院2010年1月至2023年10月间所有因EVAR术后主动脉瘤囊扩张而行移植物保留的开放瘤囊修复术病例。
- 共17例患者,中位年龄82岁,以男性为主,中位随访3年;排除移植物感染病例。
主要发现
- 58.82%的病例行网膜成形术;与瘤囊缝合相比,网膜成形术的内漏复发率有降低趋势,但无统计学显著性。
- 17.65%(3/17)患者因瘤囊进展需再干预,另2例(11.76%)因内漏复发接受监测而未再干预。
- 全部患者出院,82.35%直接回家无需康复;中位住院7天,30天死亡率为0%。
临床怎么用
- 原文结论认为,移植物保留下的开放瘤囊修复术对EVAR术后瘤囊扩张有效,可识别并修复内漏且避免主动脉阻断,术后需持续监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic sac expansion after endovascular aortic aneurysm repair (EVAR) is associated with higher reintervention rates, late rupture, and long-term all-cause mortality. Endovascular options have limitations, and guidelines recommend open sac revision (OSR) if these fail. This study reviews the technique, indications, and outcomes for OSR following EVAR at Auckland City Hospital. METHODS: We identified all OSR cases with stent-graft preservation for aortic sac expansion post-EVAR at Auckland City Hospital from January 2010 to October 2023. Techniques included sac closure, plication, or omental wrapping. Cases involving infected grafts were excluded. RESULTS: Seventeen patients (median age: 82 years, predominantly male) underwent OSR, with a median follow-up of 3 years. The primary indication was sac expansion with type 2 endoleak in 88.24% of patients, while 2 cases were type V endoleaks. Intraoperatively, endoleaks were found in 94.12% of patients, with 88.24% having type 2 endoleak and 17.65% having type 3 endoleaks. Omentoplasty was performed in 58.82% of cases. Although not statistically significant, there was a trend toward lower endoleak recurrence with omentoplasty than sac closure. Reintervention for progressive sac expansion was required in 17.65% of patients (3/17), with 2 additional patients (11.76%) monitored for recurrent endoleak without further intervention. All patients were discharged, with 82.35% going home without needing rehabilitation. The median hospital stay was 7 days, and the 30-day mortality rate was 0%. CONCLUSION: OSR with graft preservation is effective for sac expansion post-EVAR, facilitating endoleak identification and repair while avoiding aortic clamping. Ongoing surveillance is necessary.
引用
- Dean A, Hassan S, Yasutomi M, et al. Beyond Endovascular Solutions: Open Sac Revision with Graft Preservation for Persistent Aortic Sac Expansion Post-EVAR. Ann Vasc Surg. 2025. PMID: 40081528. doi:10.1016/j.avsg.2025.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。